Invention Grant
- Patent Title: 9-substituted 8-oxoadenine compound
- Patent Title (中): 9-取代的8-氧代腺嘌呤化合物
-
Application No.: US10593691Application Date: 2005-03-24
-
Publication No.: US08012964B2Publication Date: 2011-09-06
- Inventor: Ayumu Kurimoto , Yoshiaki Isobe , Stephen Brough , Hiroki Wada , Roger Bonnert , Thomas McInally
- Applicant: Ayumu Kurimoto , Yoshiaki Isobe , Stephen Brough , Hiroki Wada , Roger Bonnert , Thomas McInally
- Applicant Address: JP Osaka-Shi, Osaka SE Soedertaelje
- Assignee: Dainippon Sumitomo Pharma Co., Ltd.,Astrazeneca Aktiebolag
- Current Assignee: Dainippon Sumitomo Pharma Co., Ltd.,Astrazeneca Aktiebolag
- Current Assignee Address: JP Osaka-Shi, Osaka SE Soedertaelje
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- Priority: JP2004-093672 20040326
- International Application: PCT/JP2005/005401 WO 20050324
- International Announcement: WO2005/092893 WO 20051006
- Main IPC: C07D473/18
- IPC: C07D473/18 ; A61K31/522 ; A61P37/06 ; A61P37/08 ; A61P11/06

Abstract:
The present invention provides an 8-oxoadenine compound having immunemodulating activities such as an interferon inducing activity and useful as an antiviral agent and antiallergic agent, which is represented by the following formula (1): [wherein the ring A represents a 6-10 membered aromatic carbocyclic ring and the like, R represents a halogen atom, an alkyl group and the like, n represents an integer of 0-2, Z1 represents alkylene, X2 represents oxygen atom, sulfur atom, SO2, NR5, CO, CONR5, NR5CO and the like, Y1, Y2 and Y3 represent independently a single bond or an alkylene group, X1 represents oxygen atom, sulfur atom, NR4 (R4 is hydrogen atom or an alkyl group) or a single bond, R2 represents a substituted or unsubstituted alkyl group, R1 represents hydrogen atom, hydroxy group, an alkoxy group, an alkoxycarbonyl group or a haloalkyl group] or its pharmaceutically acceptable salt.
Public/Granted literature
- US20070190071A1 9-Substituted 8-oxoadenine compound Public/Granted day:2007-08-16
Information query